MTOR and hepatocellular carcinoma: Recent studies have identified increased stemness in HCC cells as a significant factor contributing to drug resistance.[6] Importantly, in this study, we noticed a strong association between circRNA‐mTOR, HCC progression, and targeted drug‐resistance phenotypes.